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To simulate transient B cell activation that is the likely
initiator of T-dependent responses, we examined
the molecular and functional consequences of a
single round of immunoglobulin M (IgM) signaling.
This form of activation triggered early cytosolic
signaling and the transcription factor NF-kB acti-
vation indistinguishably from conventional con-
tinuous IgM crosslinking but did not induce G1
progression. However, single round IgM signaling
changed the expression of chemokine and chemo-
kine receptor genes implicated in initiating T-depen-
dent responses, as well as accentuated respon-
siveness to CD40 signaling. Several features of
single-round IgM signaling in vitro were recapitulated
in B cells after short-term exposure to antigen in vivo.
We propose that transient BCR signals prime B cells
to receive T cell help by increasing the probability of
B-T encounter and creating a cellular environment
that is hyper-responsive to CD40 signaling.INTRODUCTION
The B cell antigen receptor (BCR) is essential for cell survival and
immune responses (Kraus et al., 2004; Niiro and Clark, 2002).
The enigmatic nature of BCR-initiated survival signals has
been clarified through the demonstration of a key role for PI3-
kinase (Srinivasan et al., 2009). Antigen binding to the BCR,
which is mimicked by BCR crosslinking, activates Src kinases
that phosphorylate immune receptor-based activation motifs of
Iga and Igb. Phosphorylated Iga and -b recruit and activate the
tyrosine kinase Syk, leading to phosphorylation of downstream
effector molecules such as BLNK, BCAP, and BAM32 that
mediate activation of MAP and PI3 kinases essential for cell
proliferation and survival (Harwood and Batista, 2008; Kurosaki
et al., 2010). Genetic mutations of these signaling proteins
corroborate their essential role in B cell responses (Niiro et al.,
2002; Shinohara and Kurosaki, 2006).Cytosolic signaling occurs within minutes of BCR crosslinking;
however, B cell proliferation is only evident after 2 days of activa-
tion (Proust et al., 1985). Because the BCR is rapidly capped and
endocytosed in response to crosslinking (Gazumyan et al.,
2006), the cell surface loses detectable IgM within a few minutes
of activation. The continued need for anti-IgM to induce prolifer-
ation is, therefore, thought to reflect re-expression of surface Ig
followed by immediate endocytosis in response to crosslinking.
In this way, signals persist despite undetectable cell surface Ig
during most of the activation period. Because receptor re-
expression is relatively slow and takes several hours to reach
half-maximal levels (Ferrarini et al., 1976), signaling via re-ex-
pressed receptors may be different from that of initial receptor
crosslinking. Thus, the cellular response to continuous BCR
stimulation is a superposition of effects of initial BCR crosslink-
ing, re-expressed BCR crosslinking, and internalized BCR
signaling. The contribution of each component to the ultimate
outcome is not clear.
The question of duration and function of Ig signals has been
previously addressed.DeFranco et al. (1985) identified a commit-
ment stage that occurs 8–10 hr prior to onset of S phase, beyond
which anti-IgM signaling is no longer required. Though the anal-
ysis was carried out before molecular signatures of cell cycle
were readily available, it is likely that this step corresponds to
the G1-S restriction point characterized by hyperphosphoryla-
tion of retinoblastoma (Rb) protein, release of the E2F family of
transcription factors, and consequent induction of S-phase
genes (Blomen and Boonstra, 2007). In addition, they found
that early steps of G1 progression, as assessed by increased
cell size, were effectively activated by lower concentrations of
anti-IgM than those required for cells to progress to the commit-
ment stage. The molecular basis for this, and the intracellular
events that occur between the initial phosphorylation cascade
and progression through G1, remain unclear.
Much is known about signaling cascades activated by key
B cell surface molecules. Anti-IgM signaling that culminates in
cell proliferation is used as a surrogate for T-independent
B cell responses, and CD40 activation is used to simulate B cells
receiving T cell help. Additionally, signaling via coreceptors,
such asCD19, or inhibitory receptors, such asCD22 or Fc recep-
tors, has also been extensively examined. An aspect of B cell
activation that is relatively understudied is the steps that leadImmunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc. 355
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Figure 1. Pulsed Activation Induces Cell Death without G1 Progression
Purified spleen B cells were activated according to the scheme shown in Figure S1A. For pulsed (single-round) BCR activation, cells were incubated with F(ab0)2
anti-IgM (10 mg/ml) on ice for 30 min, washed with cold PBS, resuspended in fresh cold medium, and moved to a 37C incubator. At various times thereafter,
viability was determined by propidium iodide (PI) exclusion with flow cytometry (B) or whole-cell extracts (WCE) prepared for protein analyses (A, C, and D).
For continuous activation, anti-IgM was bound to cells on ice for 30 min and then moved directly to 37C without intermediate washing steps.
(A) Early signal transduction in pulse (p) and continuously (c) activated cells. WCE prepared at times shown above the lanes were examined by immunoblotting.
‘‘p’’ prefix denotes the phosphorylated form of the kinase. Protein loading was normalized against PKCm or b-actin. Data shown are representative of three inde-
pendent experiments.
(B) Cell viability (y axis) after pulsed (p, blue line), continuous (c, red line), or no anti-IgM (black line) treatment was determined by PI exclusion at the times indi-
cated (x axis). Data shown are the average of nine independent experiments. Error bars represent the standard deviation (SD) between experiments. *p = 0.017,
p = 0.013, and p = 0.034 between pulsed and no anti-IgM at 24, 48, and 72 hr time points, respectively. #p < 0.001 between continuous and no anti-IgM treatment
at 48 and 72 hr by Mann-Whitney U test.
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Single Round of BCR Signaling in Naive B cellsup to T-dependent immune responses. BCR-bound antigens are
taken up by B cells and processed for presentation on MHC
class II (MHC-II) to activate antigen-specific CD4+ T cells.
Once activated, CD4+ T cells secrete cytokines and express
CD40 ligand, both of which substantially impact subsequent
B cell responses. However, it is not clear whether antigen uptake
alters B cell physiology and, if so, with what consequence. It is
also unclear how a B cell that has taken up antigen finds the
right T cell, how long it has to do so, or what happens if it
does not.
In this paper we used a pulsed activation protocol to exam-
ine molecular and functional consequences of a single round
of BCR signaling. We found that this restricted form of signaling
activated early cytosolic pathways identical to those seen in
cells treated continuously with anti-IgM, including MAP and
PI3 kinases and the first of two phases of NF-kB induction.
However, these signals were insufficient for G1 progression or
to rescue B cells from cell death. Pulsed activation upregulated
MHC-II expression on the cell surface and had long-lasting
effects on cell physiology that included induction of chemokine
and chemokine receptor gene expression. Additionally, pulse-
activated cells were hyper-responsive to CD40 signals. Several
features of pulse activation, including hyper-responsiveness to
CD40, were recapitulated in mice after short-term exposure of
B cells in Vh186.2 mIgM-Tg mice to (4-hydroxy-3-nitrophenyl)a-
cetyl (NP)-BSA. We propose that a single round of BCR signaling
primes B cells in multiple ways to receive T cell help.
RESULTS
We hypothesized that antigen uptake via the BCR, en route
to T-dependent responses, may provide transient signals to
B cells. In the most extreme form of transient signaling, BCR
crosslinking and endocytosis occur only once. To achieve this,
we bound anti-IgM to spleen B cells at 4C, removed unbound
anti-IgM from themedium, and then initiated signaling by placing
the cells at 37C. We reasoned that this experimental protocol
provided a single round of BCR-initiated signals because re-
expressed receptors could not be re-crosslinked because of
absence of anti-IgM in the medium. We shall refer to this as
pulsed activation. In order to make the best comparisons, cells
for continuous stimulation were also incubated with anti-IgM at
4C and then raised to 37C without washing out unbound
anti-IgM (Figure S1A available online).
Signaling Consequences of Pulsed Activation
Cytosolic signaling was assayed in pulse (p) or continuously (c)
activated cells by immunoblotting for phosphorylated proteins.
Syk, ERK1, -2, and p38 activation was identical between the
two forms of signaling (Figure 1A). In contrast, Akt phosphoryla-
tion at Ser473 and Thr308 was induced transiently by pulsed(C) Pro- and antiapoptotic protein expression in activated B cells. WCE from pu
immunoblotted with antibodies against antiapoptotic Bcl-2 family proteins or BH
ments.
(D) Molecular analysis of cell-cycle progression. B cells were activated by pulse (
analysis of molecular markers of G1 progression by immunoblotting of WCE. Re
(E) G1 progression analysis by cell size. Live B cells were analyzed by forward an
tative flow cytometry pattern at 24 hr time point is shown. The average of six indsignaling (Figure 1A, lanes 3, 5, and 7), but required continuous
anti-IgM treatment to be effectively maintained beyond 60 min,
particularly at Ser473 (Figure 1A, lanes 8, 10, and 12). Because
Akt is activated downstream of PI3K, we infer that a pulse of
BCR signaling activates, but does not maintain, PI3K activity.
Thus, one of the signaling consequences of re-expressed recep-
tors during continuous anti-IgM treatment is to maintain PI3K
activity.
Unlike continuous anti-IgM treatment, pulsed activation led to
increasedB cell apoptosis (Figure 1B). To determine the cause of
cell death, we examined expression of anti- and proapoptotic
proteins over a 24 hr period (Figure 1C). Bcl-2 protein was down-
regulated during ex vivo incubation, while long-term induction of
Bcl-xL, A1, and Mcl-1 required continuous activation with anti-
IgM (Figure 1C, compare lanes 6 and 7 with lanes 9 and 10).
Of the proapoptotic proteins examined, the amount of Bim
increased transiently in response to pulsed activation (lane 4),
whereas Bax was largely unaffected by either form of stimula-
tion. Though Bim expression was highest in continuously acti-
vated cells, its effect was presumably offset by compensatory
increase in Bcl-xL, A1, andMcl-1 proteins. Taken together, these
observations indicated that pulse activated cells died due to
inefficient long-term induction of antiapoptotic Bcl-2 family
proteins.
Pulsed Stimulation Is Insufficient for G1 Progression
Hallmarks of G1 progression include activation of cyclin
D-Cdk4, 6 complexes in early-mid G1, hyperphosphorylation
of Rb in late G1, and activation of cyclin E-Cdk2 complexes
at the G1-S boundary (Piatelli et al., 2003). In addition, c-myc
induction and downregulation of p27Kip1 (p27) are considered
essential to proceed through G1 (de Alboran et al., 2001;
Soeiro et al., 2006). Although Myc mRNA induction was very
similar between pulse- and continuously activated cells (Fig-
ure S1D), most other signatures of G1 progression were
impaired in pulse-activated B cells (Figure 1D). We observed
transient induction of Cdk4 (Figure 1D, lane 4) and virtually
no induction of cyclin D2, cyclin E, and Cdk2 in response to
pulse activation (Figure 1D, lanes 4, 7, and 10). Likewise, Rb
hyperphosphorylation and p27 degradation occurred most
effectively in continuously activated cells (Figure 1D, lanes 6
and 9). In keeping with the lack of molecular signatures of G1
progression, pulse-activated cells remained small as estimated
by flow cytometry (Figure 1E, averaged data in Figure S1C).
We conclude that normal early cytosolic signaling and Myc
mRNA induction are insufficient for G1 progression in pulse-
activated cells.
Pulsed Stimulation Induces Phase 1 NF-kB
Bcl2l1 (encoding Bcl-xL) and Myc have been previously
proposed to be NF-kB target genes (Duyao et al., 1990; Leelse (p) or continuously (c) activated cells prepared at the indicated times were
3-only proteins. Data shown are representative of three independent experi-
p) or continuous (c) anti-IgM treatment, and cell-cycle progression followed by
presentative blots of three independent experiments are shown.
d side scatter to estimate frequency of enlarged cells (Figure S1B). Represen-
ependent experiments is shown in Figure S1C.
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Figure 2. Pulsed Activation Induces Only
Phase I NF-kB
B cells were activated by anti-IgM using three
schemes as described below. At various times
after activation, nuclear extracts (NE) or WCE
were prepared as outlined in Experimental Proce-
dures, assayed by immunoblotting using anti-
bodies against NF-kB family members, RelA and
c-Rel, as indicated. TATA-binding protein (TBP)
and b-actin were used as the loading controls for
NE and WCE, respectively.
(A and B) Anti-IgM was added to B cells main-
tained at 37C to imitate conventional continuous
anti-IgM activation. At the indicated times, protein
extracts were prepared and analyzed by immuno-
blotting. Analysis of corresponding WCE for IkB
expression is shown in Figure S2A.
(C–F) B cells were treated with anti-IgM at 4C for
30 min and then raised to 37C with, or without,
washing to remove excess unbound anti-IgM to
initiate pulse (p, in E and F) or continuous (c, in C
and D) activation (see scheme in Figure S1A).
Data shown is representative of three independent
experiments with each activation protocol. IkB
expression in corresponding WCE is shown in Fig-
ures S2B and S2C and quantitation of biphasic
c-Rel activation in Figure S2D.
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Single Round of BCR Signaling in Naive B cellset al., 1999). Because both genes were induced in response to
pulse activation, we examined NF-kB induction in pulsed and
continuously stimulated cells. Addition of anti-IgM to splenic
B cells maintained at 37C resulted in rapid, but transient
(6 hr), activation of nuclear RelA (p65) and c-Rel (Figure 2A).
At longer time points, we observed a second wave of nuclear
c-Rel in the absence of RelA (Figure 2A, lanes 5–7). We shall refer
to these as Phase I and II NF-kB responses. Phase I coincided
with reduced IkBa expression (Figure S2A), indicating it was
mediated by the canonical posttranslational NF-kB activation
pathway. Phase II was not associated with IkB degradation,
but with increased total levels of cellular c-Rel (Figure 2B, lanes
6 and 7). A qualitatively similar, though delayed, biphasic
response occurred when cells were treated with anti-IgM at
4C and then raised to 37C, according to the ‘‘continuous’’
scheme in Figure S1A (Figure 2C, averaged data in Fig-
ure S2D). Here the Phase I response peaked around 3–6 hr,
and new c-Rel synthesis was evident beyond 18h of activation
(Figure 2D). Our interpretation is that an extended phase I over-
lapped with synthesis-dependent phase II to reduce the minima
in c-Rel expression between the two phases.
Pulsed activation resulted in only phase I NF-kB induction.
Both RelA and c-Rel translocated rapidly, but transiently, to
the nucleus of pulse-activated cells, whereas long-term c-Rel
induction was not detected (Figures 2E and 2F). As seen in cells
treated continuously with anti-IgM, phase I induction in response358 Immunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc.to pulse-activation coincided with IkBa
degradation (Figure S2C). We conclude
that BCR crosslinking induces two tem-
porally distinct phases of NF-kB acti-
vation. Phase I, which involves RelA and
c-Rel and lasts approximately 6 hr, isthe response to a single round of antigen receptor signaling;
phase II is mediated by de novo c-Rel synthesis and requires
continued stimulation by anti-IgM. Thus, transient Bcl-xL and
Myc mRNA induction observed in response to pulse activation
is likely to be the consequence of phase I NF-kB.
Gene Expression in Pulse-Activated B Cells
To gain insight into gene regulatory consequences of pulsed
versus continuous anti-IgM stimulation, we compared mRNA
profiles over a 9 hr time course using Illumina 22K oligonucleo-
tide microarrays. Two features were readily evident. First, there
was considerable overlap between up- and downregulated
genes in response to either form of stimulation (Figure 3A).
For upregulated genes, the maximum overlap occurred at early
time points (0.5–3 hr), whereas downregulated genes overlap-
pedmaximally at an intermediate time point (3 hr). Pulsed activa-
tion induced conventional immediate early genes such as Fos,
Jun, Egr1, and Egr2, and additional genes that were involved in
cytoskeletal rearrangements, plasma membrane components,
and cytosolic signaling molecules (Table S1A). Consistent with
the similarity in early signaling events in pulse and continuously
activated cells, Ingenuity pathway analysis of the RNA data set
showed identical activation of the MAP kinase pathway (Fig-
ure 3B). In contrast, the NF-kBpathwaywas transiently activated
in pulsed cells (Figure 3C), presumably reflecting the lack of
phase II NF-kB induction. Second, pulsed activation led to
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Figure 3. Pulsed Activation Causes Long-
Term Changes in Gene Expression
(A) B cells were activated with pulsed or con-
tinuous anti-IgM, according to the scheme in
Figure S1A. Total RNA isolated at the indicated
times was converted to cDNA and hybridized to
22K Illumina arrays as detailed in Experimental
Procedures. At each time point, statistically signif-
icant genes that were up- (top row) or downregu-
lated (bottom row) in response to anti-IgM were
compared between pulse- (p) or continuously (c)
activated cells. Blue and red circles represent the
mRNAs that are changed as a consequence of
pulsed or continuous anti-IgM treatment, respec-
tively; the size of circles is proportional to the
numbers of genes in each pool as indicated, and
the extent of overlap represents changes that
were common to both forms of stimulation.
The number of shared genes between the two
forms of activation is shown in the overlap. The
percentage of altered mRNAs shared between
pulse- and continuously activated cells is indicated
below the circles. Data shown are derived from
three independent experiments. See Table S1
for gene expression data.
(B and C) The RNA data from (A) was analyzed
using Ingenuity Pathway analysis software.
The pathway Z scores for MAPK associated and
NF-kB-induced mRNAs relative to unactivated
cells is shown (y axis) as a function of time
(x axis) for pulse (blue bars) and continuous (red
bars) activation regimens.
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Single Round of BCR Signaling in Naive B cellslong-term changes in gene expression that lasted up to 9 hr after
the stimulus. Strikingly, many up- and downregulated genes at
the 9 hr time point were unique to each form of stimulation
(Tables S1B and S1C). We conclude that a single round of
BCR signaling substantially alters the resting state of B cells
for prolonged time periods.
Functional Consequences of Pulse Activation
The diversity of gene expression changes induced by a single
round of BCR activation prompted us to look for genes that
may affect B cell function. We first focused on possible targets
of phase I NF-kB activation. Microarray analyses revealed that
pulsed activation rapidly induced expression of the genes
encoding chemokines CCL3 and CCL4, as well as the gene
encoding the chemokine receptor CCR7 (Figure S3). These
genes were of particular interest because CCL3 and -4 are
known chemoattractants for CD4+ T cells (Bystry et al., 2001;
Taub et al., 1993), and CCR7 has been implicated in the migra-
tion of activated B cells toward the T cell zone of the spleen
(Reif et al., 2002). We confirmed the microarray data using quan-
titative RT-PCR (qRT-PCR) (Figures 4A–4C, left panels). Addi-
tionally, these results were corroborated by ELISAs measuring
chemokine protein in culture supernatants from pulse-activated
cells (Figures 4A and 4B, right panels) and by flow cytometry for
cell-surface CCR7 expression (Figure 4C, right panel). One of the
major functions of activated B cells is to present MHC-II-bound
antigenic peptide to CD4+ T cells. MHC-II has been previously
shown to be upregulated by BCR crosslinking (Marshall-Clarke
et al., 2003). We found that single-round BCR uptake was
sufficient to increase surface MHC-II expression (Figure 4D).We infer that pulsed activation increases the probability of
B cell encounter with T cells and potentiates antigen presenta-
tion by elevating MHC-II expression.
To determine whether pulse-activated B cells also altered their
responsiveness to receiveTcell help, naiveBcellswereactivated
with a single-round of BCR cross-linking, and after 6h, treated
with CD40 antibody for an additional 18 or 42h (Figure S4A).
Anti-CD40 treatment rescued untreated or pulse anti-IgM treated
Bcells fromcell death (FigureS4B).Moreover, cells that hadbeen
pulsed with anti-IgM 6h prior to anti-CD40 treatment, underwent
blast formation 4-fold more effectively than naive B cells at 24h
(Figure 5A). Higher blast formation was also apparent after 42h
of anti-CD40 stimulation, but the synergistic effect was less
pronounced (Figure 5A, bar graph). We confirmed that this was
a feature of mature follicular B cells using CD21+CD23int cells
purified by flow cytometry (Figure 5B). Cells treated continuously
with anti-IgM also respondedmore efficiently to anti-CD40 treat-
ment (Figure S4C). We used immunoblotting to examine molec-
ular hallmarks of G1 progression. Compared to either stimulus
alone, we found increased expression of Cdk2 and 4, cyclin D2
and E, and hyperphosphorylated Rb in pulse-activated cells
that had been treated with anti-CD40 for additional 18h
(Figure 5C, lane 7 compared to lanes 5, 6). However, CD40 acti-
vation alone was sufficient to induce p27 degradation (Figure 5C,
lane 5). We conclude that a pulse of BCR signaling primes B cells
to respond more effectively to CD40.
In Vivo B Cell Priming
We extended our analysis to determine whether antigen-specific
priming occurred in culture. For this, we utilized mIgM-Tg miceImmunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc. 359
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Figure 4. Pulsed Activation Induces Che-
mokines and Cell Surface Receptors
Involved in B-T Interaction
(A and B) B cells were activated with pulse (p) or
continuous (c) anti-IgM stimulation. At various
times after initiation of signaling, Ccl3 (A), Ccl4
(B) mRNA, and secreted proteins were examined
by qRT-PCR (see also Figure S3) or ELISA, respec-
tively. Ccl3 and Ccl4 mRNAs were normalized to
Actin mRNA. Data shown is the average of two
independent RNA time-course experiments, with
RT-PCR assays being carried out in duplicates.
For analysis of secreted chemokines, culture
medium from untreated or pulse-treated B cells
were collected at 6 and 12 hr time points. CCL3
and CCL4 protein was detected by ELISA. Data
shown are the average ± SD of three independent
experiments. p values were calculated by Mann-
Whitney U test.
(C)Ccr7mRNA expression was examined by qRT-
PCR as described in parts A and B; y axis indicates
the fold increase in normalized Ccr7 mRNA
expression compared to 0 hr. To detect cell-
surface expression of CCR7 protein, cells were
harvested at 24 hr after activation and immuno-
stained using CD197-FITC antibody. Data shown
are representative of three independent experi-
ments. Median fluorescence intensities (MFI) of
CCR7 expression for unactivated (black), continu-
ously (red), and pulsed (blue) activated cells were
56.5 ± 7.7, 91 ± 14.1, and 86 ± 1.4, respectively.
(D) Cell-surface expression of MHC-II protein.
Cells were harvested at 12 hr after pulsed or
continuous activation, stained and analyzed by
flow cytometry. Data shown are representative of
three independent experiments. MFIs of MHC-II
expression for unactivated (black), continuously
(red), and pulsed (blue) activated cells were
269 ± 74, 2320 ± 179, and 1544 ± 83, respectively.
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Single Round of BCR Signaling in Naive B cellsthat carry a Vh186.2 Ig heavy-chain transgene that lacks secre-
tory m exons bred to a JH- and Jk-deficient background (Hannum
et al., 2000). Approximately half of the B cells (that express Vl1) in
this strain bind to the hapten NP. Compared to cells treated with
anti-CD40 alone, only antigen-specific B cells responded better
after being primed with NP-BSA (see details in Figures S5A–
S5C). However, anti-IgM pulsing evoked comparable responses
from NP-specific and -nonspecific B cells. We conclude that
transient exposure to antigen enables B cells to respond more
efficiently to subsequent CD40 activation.
Having ascertained that NP-specific B cells in mIgM-Tg mice
could be primed ex vivo, we followed the scheme shown in
Figure S5D to test whether this occurred in vivo. Because
mIgM-Tg mice lack secreted antigen-specific antibody, this
strain permits direct exposure of B cells to defined amounts of
conjugated hapten in vivo. We injected mIgM-Tg mice intrave-
nously with NP-BSA in PBS or PBS alone; splenic B cells were
isolated after 2 hr, incubated ex vivo for 4 hr to recapitulate
the time duration between pulse activation and anti-CD40360 Immunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc.treatment in the in vitro experiments, and then treated with
anti-CD40. B cell activation was assessed by CD69 expression,
and cell size was assessed by flow cytometry.
At 24 hr, anti-CD40 treatment induced CD69 expression on
the majority of cells regardless of whether they were obtained
from NP-BSA- or PBS-injected mice; this was true for antigen-
specific (NIP[+]) and non-specific (NIP[]) cells alike (Figure 6A,
top panels). However, the proportion of enlarged CD69+ cells
with anti-CD40 was 2-fold higher only in the NIP-binding popula-
tion in NP-BSA-injected mice compared to PBS-injected mice
(Figure 6A, averaged in top graph labeled 24 hr). Thus, 2 hr
NP-BSA treatment in vivo selectively increased CD40 respon-
siveness of antigen-specific B cells. Because CD69 is con-
sidered an early activation marker, we used different gates
to analyze the state of cells after 48 hr (Figure 6A, bottom
panels). Again, we found that NP-BSA immunization selectively
enhanced the response of antigen-specific B cells as judged
by the proportion of enlarged cells; the difference between
antigen-specific and -nonspecific cells in the same animal was
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Figure 5. Pulsed Activation Primes B Cells to Respond to CD40 Signals
B cells were left untreated or pulse-activated (p) at 0 hr. Six hours later, anti-CD40 was added to both cultures, and 18 hr later, cells harvested to assay G1
progression by flow cytometry and molecular markers (Figure S4A).
(A) Representative flow cytometric analysis of CD40 responsiveness of pulse-activated cells gated on live cells. Enlarged cells compared to the starting naive
B cell population were scored as described in Figure S1B. Bar graph shows the average of eight independent blast formation experiments, represented as
the percentage of cells that fall in the enlarged cell gate. Bars represent average ± SD between experiments. *p < 0.001 between treatments by Mann-Whitney
U test.
(B) Sorted follicular B cells (Figure S4D) were activated by pulse (p) anti-IgM and anti-CD40, and cell-cycle progression followed by cell size using flow cytometry.
Representative flow cytometry pattern after 18 hr anti-CD40 treatment is shown. Bar graphs the average ± SD of three experiments. **p < 0.01 between treat-
ments by Mann-Whitney U test.
(C) WCEs prepared from cells activated according to the scheme described above were blotted with antibodies against the G1 phase markers. Data shown are
representative of three independent experiments.
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Single Round of BCR Signaling in Naive B cellsreadily apparent (Figure 6A, averaged in bottom graph labeled
48 hr). Based on both assays, we conclude that transient expo-
sure to antigen in vivo heightens the response of B cells to
subsequent CD40-initiated signals.
To obtain additional evidence of in vivo priming, we sought
amolecular read-out of pulse versus continuous anti-IgM activa-
tion. From our microarray analyses, we picked and confirmedseveral candidate genes that were selectively induced in
pulse-activated cells (Figure S5E). We then used RNA obtained
from B cells of NP-BSA injected mice to evaluate antigen-
induced activation of these genes. We found that all four genes
were induced in response to transient NP-BSA exposure (Fig-
ure 6B). The close correspondence between pulse-activated
cells in vitro and transiently antigen-activated cells in vivo leadsImmunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc. 361
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Figure 6. In Vivo B Cell Priming
mIgM-Tg mice were injected intravenously with PBS alone (two animals) or 250 mg NP-BSA in PBS (three animals). Two hours later, splenic B cells were isolated
and incubated ex vivo for 4 hr, followed by anti-CD40 treatment. RT-PCR assays and flow cytometry analyseswere performed at indicated time points (see exper-
iment scheme in Figure S5D).
(A) Representative flow cytometric analysis of B cells at 24 hr (top panels) and 48 hr (bottom panels) after animal immunization and ex vivo culture with or without
anti-CD40. Antigen-specific B cells were detected using fluoresceinated NIP ([4-hydroxy-3-nitro-2-iodo-phenyl]acetyl). For 24 hr analysis, NIP() and NIP(+) alive
B cells were further scored for CD69 expression and cell size by forward scatter. Cells that were not treated with anti-CD40 are marked ‘‘none,’’ and their origin
from PBS-injected or NP-BSA-injected is indicated on the left. Gating for CD69+ cells is shown by the blue box and for enlarged cells by the red box. For 48 hr
analysis, cells were analyzed for antigen specificity (blue boxes) and cell-size increase (red line). Graphs for the 24 hr or 48 hr time points show percent of
enlarged, CD69+ cells (red box) or frequency of enlarged cells (falling to the right of the red line) among NIP-binding or not binding cells. Bar graphs represent
the average ± SD between individual animals in each treatment arm. *p < 0.05 and **p > 0.05 as determined by Mann-Whitney U test.
(B) Induction of pulse anti-IgM-specific genes. B cells were purified from spleen of NP-BSA or PBS injectedmice 2 hr after immunization. RNAwas isolated imme-
diately after purification (labeled 2) or after 4 additional hours of culture in RPMI 1640media (labeled 2+4) and assayed by qRT-PCR. The four geneswere selected
based on their inducibility at 9 hr after pulsed anti-IgM activation in vitro (Figure S5E). The level of mRNA expression after 4 hr in vitro culture (hatched bars) was
compared to freshly isolated cells from PBS-injected controls (white bars) or NP-BSA-injected animals (blue bars), with PCR assays being carried out in dupli-
cates. Bars represent average ± SD within each group. *p < 0.05 by Mann-Whitney U test.
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Figure 7. Mediators of Pulsed Activation-
Induced CD40 Hyper-responsiveness
(A) Downregulation of Bank1 by pulsed activation.
Spleen B cells (left panel) or follicular B cells
(middle panel) were activated by pulse (p) or con-
tinuous (c) anti-IgM stimulation. At various times
after initiation of signaling, Bank1 mRNA expres-
sion was examined by qRT-PCR. The RNA data
shown are the average ± SD of three independent
RNA time-course experiments. Bank1mRNA from
antigen immunized mIgM-Tg mice was quanti-
tated with RT-PCR (right panel). B cells were puri-
fied from mIgM-Tg mice injected with PBS alone
for 2 hr (labeled 2) or NP-BSA for 2 hr and B cells
from NP-BSA immunized animals that were
cultured ex vivo for an additional 4 hr without stim-
ulation (labeled 2+4). The data shown are the
average ± SD of two PBS injected mice and
three NP-BSA immunized mice.
(B) BANK protein expression was examined in
B cells left untreated () or after pulse (p) or
continuous (c) anti-IgM activation. Data shown
are representative of three independent experi-
ments (averaged in Figure S6B).
(C) Upregulation of c-Rel by pulsed activation.
Pulse (p) or continuous (c) anti-IgM treatment
was initiated at 0 hr; 6 hr later, anti-CD40 was
added for an additional 1 hr. NE were prepared
at the indicated times from anti-IgM-treated cells
or after the additional hour of anti-CD40 treatment
as indicated. RelA and c-Rel nuclear induction
was analyzed by immunoblotting. Data shown
are representative of three independent experi-
ments (averaged in Figure S6C).
(D) WCE were prepared 6 hr after pulse activa-
tion of spleen B cells with anti-IgM, as well as
after further incubation for 18 hr in the presence
or absence of anti-CD40 as indicated, and
analyzed for pro- and antiapoptotic protein expression. Data shown are representative of two independent experiments.
(E) Untreated or pulsed anti-IgM activated B cells fromWT (C57BL/6J) and c-Rel-deficient mice were activated with anti-CD40 6 hr after administration of pulse.
Twelve hours after anti-CD40 addition, the proportion of enlarged cells was quantitated by flow cytometry (see Figure S1B). The average ± SD of four experiments
is shown. p value was calculated by Mann-Whitney U test.
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several hallmarks of pulse activation. Taken together with the
functional evidence, we conclude that transient antigen expo-
sure in vivo primes B cells to receive T cell help via CD40.
Mechanism of B Cell Priming
To identify possible mechanisms of increased CD40 responsive-
ness, we screened the microarray data for regulators of CD40
signaling. We found that mRNA of the gene encoding the
B cell-specific adaptor, BANK, a negative regulator of CD40
(Aiba et al., 2006), was reduced by 90% within 3 hr of pulsed
or continuous anti-IgM treatment; thereafter, the amounts
remained low in continuously activated cells but gradually
increased in pulse-activated cells (Figure 7A, left panel; see
microarray data in Figure S6A). Downregulation of Bank1
mRNA also occurred in pulsed anti-IgM-activated follicular
mature B cells (Figure 7A, middle panel) and in spleen B cells
from NP-BSA immunized mIgM-Tg mice (Figure 7A, right panel).
To determine whether BANK protein expression was similarly
affected by BCR crosslinking, we assayed whole-cell extracts
by immunoblotting with BANK antibody. BANK protein expres-sion was reduced by both forms of BCR activation at the 8 hr
and 16 hr time points (Figure 7B, lanes 3, 4, 6, and 7; averaged
in Figure S6B), but reaccumulated only in pulse-activated cells
at 24 hr (Figure 7B, lanes 8–10). We suggest that reduced
BANK expression in response to a single round of BCR activation
may contribute to enhanced CD40 responsiveness.
To test CD40-induced NF-kB responses in pulse-activated
B cells, anti-CD40 was added 6 hr after pulse activation, and
an hour later, nuclear RelA and c-Rel were assayed by immuno-
blotting. Phase I RelA activation, that was evident at 1 hr in both
continuous and pulse activated cells, was downregulated by 6 hr
(Figure 7C, compare lanes 2 and 3 with lanes 4 and 5); nuclear
c-Rel levels decreasedmore slowly, remaining higher than back-
ground at 6 hr (Figure 7C, lanes 4 and 5). One hour anti-CD40
treatment of control, continuous, and pulse-activated cells
showed comparable RelA induction in all three samples but
2-fold enhanced c-Rel expression in anti-IgM-pre-treated cells
(Figure 7C, lanes 6–8 and averaged in Figure S6C). Accordingly,
expression of c-Rel-dependent antiapoptotic gene products,
such as Bcl-xL and A1 proteins, was also increased in response
to CD40 treatment of pulse-activated cells (Figure 7D).Immunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc. 363
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Single Round of BCR Signaling in Naive B cellsTo determine if c-Rel played a role in B cell priming, splenic
B cells from c-Rel-deficient mice were pulse activated and
treated with anti-CD40, and cell blasting was estimated by
flow cytometry. CD40 activation led to fewer enlarged cells in
BCR-primed B cells from c-Rel-deficient mice compared to
normal mice (Figure 7E). Importantly, this was not because
c-Rel-deficient B cells responded less effectively to anti-CD40
because comparable blast formation was seen after extended
times in normal unprimed or Rel/ B cells (data not shown).
We conclude that c-Rel contributes to priming naive B cells to
receive T cell help; this may occur, at least in part, via the induc-
tion of antiapoptotic protein expression.
DISCUSSION
T-dependent humoral responses require interaction between
relatively rare antigen-specific B and T cells. Moreover, subse-
quent T cell help is directed predominantly at antigen-specific
B cells to minimize by-stander B cell activation (Parker, 1993).
The molecular mechanisms that determine these critical
aspects of B cell responses are not clear. Here, we show that
the shortest possible signal via the BCR predisposes B cells
to participate in T-dependent responses by increasing the prob-
ability of encounter with CD4+ T cells, upregulating MHC-II
expression and inducing hyperresponsiveness to CD40 sig-
naling. In vitro, we delivered such a signal by binding anti-IgM,
or NP-BSA, to spleen B cells at 4C, removing excess unbound
anti-IgM or antigen, and incubating the cells at 37C. We based
this scheme on the idea that receptors re-expressed after
initial capping and endocytosis would no longer find antigen
(or anti-IgM) in the extracellular milieu for continued binding
and signaling. We substantiated these findings in vivo by
exposing B cells in mIgM-Tg mice to a single dose of antigen
in PBS, reasoning that such a protocol would deliver signals
purely to B cells without confounding effects of adjuvant.
Remarkably, this form of antigen exposure yielded B cells that
had several characteristics of pulse-activated cells, including
changes in gene expression and hyper-responsiveness to
CD40 signaling. Hence, although the exact duration of antigen
exposure to B cells in vivo is not known, it appears that a single
dose of soluble antigen recapitulates a pulsed in vitro scheme
better than a continuous one. These observations indicate that
the proposed model of partial activation and priming is physio-
logically relevant in vivo.
This priming effect was transient, being maintained for 6 hr,
but not 12 hr, after pulsed activation in vitro (data not shown).
We propose that one mechanism by which pulsed activation
makes B cells hyperresponsive to CD40 is by rapidly downregu-
lating BANK, a negative regulator of CD40 signals. However,
BANK downregulation was not sufficient to prime B cells
because BANK-deficient B cells were also primed by pulsed
anti-IgM treatment in vitro (B.D. and R.S., unpublished data).
Alternatively, BANK-deficient cells may have activated compen-
satory mechanisms to reduce CD40 responsiveness. Additional
studies are needed to distinguish between these possibilities.
Downregulation of BANK by pulsed activation was transient,
and Bank1mRNA expression was almost fully restored 9 hr after
the pulse. The kinetics of BANK re-expression may, therefore,
define the period a B cell remains in a state of heightened364 Immunity 32, 355–366, March 26, 2010 ª2010 Elsevier Inc.responsiveness to CD40. It is noteworthy that BANK amounts
remained low in cells stimulated continuously with anti-IgM,
suggesting that the duration of the primed state may vary with
the kind of signal received by B cells.
Although many aspects of BCR signaling in pulse-activated
cells were indistinguishable from the well-studied continuous
forms of anti-IgM signaling, the form and duration of Akt activa-
tion was substantially different. In particular, we noticed that
Akt phosphorylation at Ser473 continued to increase with
conventional anti-IgM treatment over a 4 hr time course,
whereas Thr308 phosphorylation decreased after 1 hr (though
it remained discernibly higher than in pulse-activated cells).
Ser473 phosphorylation has been recently shown to be medi-
ated by the rictor-TORC2 complex (Jacinto et al., 2006); impor-
tantly, its absence results in the selective defect of FoxO1 and
FoxO3a downregulation and enhanced apoptosis of mouse
embryo fibroblasts. It is therefore intriguing to speculate that
continued increase of Ser473 phosphorylation in response to
continuous anti-IgM treatment may be required to maintain
B cell viability by downregulating FoxO proteins. In pulse-acti-
vated B cells Ser473 phosphorylation is rapidly lost, which could
explain the observed increase in cell death. Lack of persistent
Akt activation may also contribute to absence of blast formation
in pulse-activated cells by affecting GLUT1 expression (Dufort
et al., 2007).
Taken together, our observations lead to the following working
model for initiation of T-dependent immune responses. A single
round of antigen binding and uptake by BCR initiates long-term
changes directed toward effective B-T collaboration. First,
MHC-II molecules are upregulated to allow antigenic peptides
to be presented to T cells. Second, phase I NF-kB induces target
genes, such as the chemokine receptor CCR7 that enables
antigen-bearing B cells to move into splenic T-rich zone; concur-
rently CCL3 and CCL4 chemokine expression serves to attract
CD4+ T cells to the antigen-primed B cells (Bystry et al., 2001;
Okada and Cyster, 2006; Reif et al., 2002). Together, these
changes in chemokines and their receptors increase the chance
of antigen-primed B cells encountering CD4+ T cells of the right
specificity. Third, if an appropriate T cell is found, its activation
via peptide-MHC-II results in expression of CD40 ligand.
Because antigen-primed B cells are particularly responsive to
receive CD40 signals, having downregulated BANK and upregu-
lated c-Rel, CD40 ligand-bearing T cell help is directed selec-
tively toward these cells. Thereby, by-stander B cell activation
is reduced. Our studies also suggest that the primed state is
transient. At the molecular level, priming is lost when chemo-
kines and chemokine receptors are downregulated and/or
BANK is upregulated, after cessation of BCR signaling. Cumula-
tively, these mechanisms minimize activation in response to
sporadic BCR stimulation while maximizing the possibility of
T-dependent B cell activation.
EXPERIMENTAL PROCEDURES
Mice and Antigen Administration
All experimental mice were 8–12 weeks old. C57BL/6J mice were purchased
from The Jackson Laboratory. Rel/ mice were provided by the laboratory
of Dr. Hsiou-Chi Liou (Cornell University Medical College). mIgM-Tg
mice carrying the Vh186.2 Ig heavy chain bred to Jk-deficient mice previ-
ously described (Hannum et al., 2000) were injected with PBS or NP-BSA
Immunity
Single Round of BCR Signaling in Naive B cells(250 mg/animal, with conjugation ratio of NP to BSA of 26) into tail vein, and 2 hr
later, the mice were euthanized for B cell purification.
Mice were treated humanely in accordance with federal government guide-
lines, and their use was approved by the respective institutional animal care
and use committees.
B Cell Isolation and Culture
Primary B lymphocytes were isolated using Auto-MACS (Miltenyi Biotec) or
RoboSep (StemCell Technologies) magnetic purification techniques by nega-
tive selection. B cell purity was 90%–95%, based on flow cytometric analysis
with CD19 staining. Isolated B cell pools contained in average 57.1 ± 9.1% of
follicular, 9.1 ± 3.4% of marginal, 5.2 ± 2.4% of T1, and 6.4 ± 3.4% of T2
B cells.
Follicular B cells were purified from negatively isolated spleen B cells by flow
cytometry (FACSAria, Beckton Dickinson) using published gating strategy
(Meyer-Bahlburg et al., 2009). Representative sorting gates and follicular
B cell purity (90%) are shown in Figure S4D.
Purified B cells (23 106/ml) were cultured in RPMI 1640 supplemented with
10% heat-inactivated FBS, 55 nM b-mercaptoethanol, 2 mM L-glutamine and
100 IU penicillin, and 100 mg/ml streptomycin at 37C.
For pulsed anti-IgM treatment experiments, B cells were incubated with
10 mg/ml goat anti-mouse IgM F(ab0)2 (Jackson ImmunoResearch Laborato-
ries) at 4C for 30 min. Unbound anti-IgM was removed from the medium by
washing and centrifuging the cells at 4C. The cells were resuspended in
chilled complete medium and shifted to 37C by placement in an incubator
or in water bath. For continuous anti-IgM treatment experiments, B cells
were stimulated with 10 mg/ml anti-IgM at 4C for 30 min, then incubated at
37C. For ‘‘priming’’ experiments, pulse- or continuously activated B cells
were incubated for 6 hr, after which 5 mg/ml monoclonal anti-CD40 (BD Phar-
migen) was added and the cells were further incubated for various time periods
depending on the assay.
Immunoblotting
For analysis of NF-kB components, 3 mg nuclear extracts, prepared as
described (Stadanlick et al., 2008), were separated by SDS-PAGE gel.
Proteins were transferred to PVDF membranes using semidry transfer, and
the membrane was probed with anti-p65 (RelA), anti-c-Rel (Santa Cruz
Biotechnology), followed by HRP-conjugated secondary antibody. Signals
were detected using an enhanced chemiluminescent (ECL) substrate (Thermo
Scientific). TATA binding protein (Abcam) was used to normalize between
nuclear extracts.
For all other immunoblottings, 10 mg whole-cell extracts prepared in RIPA
buffer (Santa Cruz) were used. Antibodies detecting phospho-Syk (Y319),
Syk, phospho-ERK1, 2 (T202/Y204), ERK1, 2, phospho-p38 (T180/182), p38,
phospho-Akt (S473), phospho-Akt (T308), Akt, Bcl-xL, Bax, p27, phospho-
Rb (S807/811), IkBa, IkBb (Cell Signaling), Cdk2, Cdk4, Cyclin D2, Cyclin E,
PKCm (Santa Cruz), A1 (R&D Systems), Mcl-1 (Rockland Immunochemicals),
Bim (BD Biosciences), Bcl-2 (Stressgen), and b-actin (Sigma) were used
according to the manufacturer’s instructions. BANK antibody was a gift from
Dr. T. Kurosaki (RIKEN Research Center for Allergy and Immunology, Japan).
ImageJ software (NIH) was used to quantitate band intensities from unsatu-
rated films.
RNA Extraction and Real-Time PCR
RNA was extracted using the RNeasy Micro Kit (QIAGEN). cDNA was synthe-
sized using random hexamers and the SuperScript First Strand Synthesis
System (Invitrogen Life Technologies). Real-time PCR was performed in dupli-
cates using the ABI Prism 7000 (Applied Biosystems). Expression of Ccl3,
Ccl4, Ccr7, Bank1, Spata13, Lincr, Gdi2, and Inpp5f mRNA was normalized
to Actin mRNA on same PCR plate. The primers used in this study were
designed using PrimerQuest online tool (Integrated DNA Technologies). Primer
sequences are shown in Supplemental Experimental Procedures.
Flow Cytometry
Cell viability was measured by flow cytometry after staining with propidium
iodide (10 mg/ml, Sigma-Aldrich). Cell size was estimated based on forward
scatter profile of viable cells (Figure S1B).CCR7, MHC-II, CD69, and NP-specific Ig cell-surface staining was done
using rat CD197-FITC (AbD Serotec), mouse I-Ab, CD69-PE antibodies (BD
PharMingen); NIP-haptenated PE (NIP-PE); APC (NIP-APC) reagents, and rat
or mouse IgG2a antibodies, with corresponding fluorophore (BD PharMingen),
as isotype control. Briefly, cells were incubated with Fc block and then stained
for 30 min with the antibodies in flow cytometry buffer (0.5% BSA in PBS),
followed by washing in excess amount of the buffer.
All measurements from in vitro experiments were carried out using FACSCa-
libur and from in vivo experiments performed using an LSR II (Beckton Dickin-
son), and data were analyzed using FlowJo software (Tree Star).
ELISA
Detection of CCL3 and -4 in culture medium was done using DuoSet ELISA
Development kits for mouse CCL3 (MIP-1a) and CCL4 (MIP-1b) (R&D
Systems) according supplier’s protocol. Briefly, 96-well flat-bottomed plates
were coated with 0.4 mg/ml or 2 mg/ml capture antibodies, respectively, for
CCL3 and CCL4. The captured CCL proteins were detected with 0.1 mg/ml
of the appropriate biotinylated goat anti-mouse CCL and streptavidin-HRP.
Illumina Oligonucleotide Microarray
Total RNA (0.5g) was used to generate biotin-labeled single-stranded RNA
using the Illumina TotalPrep RNA Amplification Kit (Ambion). Briefly, total
RNA was converted into single-stranded cDNA, with reverse transcriptase
using an oligo-dT primer containing the T7 RNA polymerase promoter site
and then copied to produce double-stranded cDNA molecules. The double-
stranded cDNA was used in an overnight in vitro transcription reaction where
single-stranded RNA (cRNA) was generated and labeled by incorporation of
biotin-16-UTP. A total of 0.75 mg of biotin labels cRNA was hybridized at
58C for 16 hr to Illumina’s Sentrix MouseRef-8 Expression BeadChips
(Illumina). The arrays were washed and blocked, and the labeled cRNA was
detected by staining with streptaviden-Cy3. The arrays were scanned using
an Illumina BeadStation 5003 Genetic Analysis Systems scanner, and the
image data were extracted using Illumina BeadStudio software.
Microarray Analysis
Microarray data were analyzed using DIANE 6.0 program. Raw microarray
data were subjected to filtering and Z normalization and tested for significant
changes as previously described (Cheadle et al., 2003). Individual genes with
Z ratios > 1.5, p value < 0.05, and fdr < 0.3 were considered significantly
changed. Ingenuity Systems Pathways Analysis (Ingenuity Systems) was
used to identify top network functions involving differentially expressed genes.ACCESSION NUMBERS
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